Fact sheet on the use of medications for safe abortion care in the misoprostol alone regimen and the combined regimen, misoprostol and mifepristone.
Author: Ipas LAC
Use of misoprostol in obstetrics
At lpas LAC, we work with a clear and determined focus: to ensure that everyone who needs contraception or access to safe abortion can obtain it in dignity and without barriers.
About Us
Ipas, founded in 1973 in North Carolina, USA, operates globally to promote reproductive justice by expanding access to abortion (referred to as menstrual regulation (MR) in Bangladesh)* and contraception.
In 2011, Ipas began operations in Bangladesh, collaborating with the Ministry of Health and Family Welfare (MoHFW), Directorate General of Family Planning (DGFP), Directorate General of Health Services (DGHS), Directorate General of Nursing and Midwifery (DGNM), NGOs, donors, and stakeholders for strengthening the health system. Initially focusing on menstrual regulation (MR), postabortion care (PAC), and family planning (FP) services, our efforts have evolved to advocate for institutionalized sexual and reproductive health and rights (SRHR) services.
Recent Comments